
Opinion|Videos|April 21, 2025
Factoring Cost, Recommendations, and Evidence Into Formulary Decisions about Lp(a) Testing
Experts discuss the cost of lipoprotein(a) (Lp[a]) tests and how these costs, along with the National Lipid Association’s (NLA) recommendation and supporting clinical evidence, may influence payer decisions regarding coverage for Lp(a) testing.
Advertisement
Video content above is prompted by the following:
- How expensive are Lp(a) tests?
- How might these costs, the NLA’s recommendation, and the supporting clinical evidence factor into payer decisions about whether to cover Lp(a) testing?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Respiratory Vaccination by the Numbers: COVID-19, Flu, and RSV
2
Inside the 24-Hour Reversal of SAMHSA Grant Cuts With NAMI's Jennifer Snow, MPA
3
Anti-Inflammatory, Antioxidant-Rich Diets May Lower Skin Cancer Risk, Slow Biological Aging
4
Corticosteroids Associated With Development of Comorbidities in Myasthenia Gravis
5




























































